Slayden O D, Zelinski-Wooten M B, Stouffer R L, Brenner R M
Division of Reproductive Sciences, Oregon Regional Primate Research Center, Beaverton 97006.
J Clin Endocrinol Metab. 1994 Aug;79(2):620-6. doi: 10.1210/jcem.79.2.8045986.
We and others have detected progesterone receptors (PR) in the primate (macaque and human) corpus luteum by immunocytochemistry. However, we have been unable to measure PR in the corpus luteum by conventional ligand binding assay, presumably because high endogenous concentrations of progesterone (P) in luteal tissue prevented specific binding of radiolabeled hormone to PR during the assays. To test this hypothesis, we treated monkeys with the 3 beta-hydroxysteroid dehydrogenase inhibitor, Trilostane, to reduce levels of endogenous P before conducting binding assays for PR in luteal tissue. To obtain adequate tissue for saturation analysis, rhesus monkeys (n = 6) were superovulated by treating them with hFSH beginning at menses (day 1) for 6 days, then with hFSH and hLH (days 6-9), followed by hCG (day 10). Trilostane (600 mg) was given 5 days after hCG treatment (day 15), and binding assays were conducted 18 h later. Trilostane significantly reduced mean (+/- SE) serum levels of P from 97.8 +/- 16 to 2.7 +/- 1.3 nmol/L within 18 h (P < 0.001). Strong nuclear staining of PR was detected by immunocytochemistry in both Trilostane-treated and control (not Trilostane-treated) tissue, but ligand binding was measurable only in Trilostane-treated monkeys. Scatchard transformations of saturation curves revealed high affinity binding of [3H] R5020 in luteal cytosol and nuclear extracts with an approximate dissociation constant (Kd) of 4.8 and 1.37 nmol/L, respectively. Also, the PR-specific monoclonal antibody, JZB-39, shifted a [3H]R5020-bound luteal macromolecule on sucrose gradients. Mean cytosolic and nuclear binding of [3H]R5020 were 0.31 +/- 0.09 and 0.06 +/- 0.02 fmol/micrograms DNA, respectively. Similar binding of [3H]R5020 was demonstrated in corpora lutea obtained during spontaneous menstrual cycles after Trilostane treatment (n = 3). These results show unequivocally that the PR in macaque luteal tissue can bind P with high affinity and suggest a receptor-mediated action of P in the primate corpus luteum.
我们和其他研究人员已通过免疫细胞化学方法在灵长类动物(猕猴和人类)的黄体中检测到孕激素受体(PR)。然而,我们一直无法通过传统的配体结合试验来测定黄体中的PR,推测可能是因为黄体组织中内源性孕激素(P)的浓度过高,在试验过程中阻止了放射性标记激素与PR的特异性结合。为了验证这一假设,我们在对黄体组织进行PR结合试验之前,用3β-羟基类固醇脱氢酶抑制剂曲洛司坦治疗猴子,以降低内源性P的水平。为了获得足够的组织进行饱和分析,恒河猴(n = 6)在月经周期第1天开始用hFSH治疗6天进行超排卵,然后用hFSH和hLH(第6 - 9天),随后用hCG(第10天)。在hCG治疗后5天(第15天)给予曲洛司坦(600 mg),18小时后进行结合试验。曲洛司坦在18小时内将平均(±SE)血清P水平从97.8±16显著降低至2.7±1.3 nmol/L(P < 0.001)。通过免疫细胞化学在曲洛司坦治疗组和对照组(未用曲洛司坦治疗)组织中均检测到PR的强核染色,但仅在曲洛司坦治疗的猴子中可测量到配体结合。饱和曲线的Scatchard转换显示,[3H]R5020在黄体细胞质和核提取物中的高亲和力结合,解离常数(Kd)分别约为4.8和1.37 nmol/L。此外,PR特异性单克隆抗体JZB - 39在蔗糖梯度上使[3H]R50结合的黄体大分子发生迁移。[3H]R5020在细胞质和核中的平均结合量分别为0.31±0.09和0.06±0.02 fmol/μg DNA。在曲洛司坦治疗后的自然月经周期中获得的黄体中也证实了[3H]R5020的类似结合(n = 3)。这些结果明确表明,猕猴黄体组织中的PR能够以高亲和力结合P,并提示P在灵长类动物黄体中存在受体介导的作用。